Navigation Links
NUCRYST Announces First Quarter 2008 Financial Results
Date:5/6/2008

WAKEFIELD, MA, May 6 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced its financial results for the first quarter ended March 31, 2008. Total revenues were $5.2 million for the first quarter of 2008, as compared with $5.2 million in the first quarter of 2007. Total revenues in the first quarter 2008 include wound care product revenues of $6.3 million, a 21% increase from $5.2 million in the first quarter of 2007, which was offset by the recognition during the quarter of $1.1 million of a $4.5 million manufacturing cost rebate paid annually to Smith & Nephew under our supply agreement.

Net loss for the first quarter of 2008 was $2.2 million, or $0.12 per share, compared to a net loss of $1.9 million, or $0.10 per share, for the same period last year. As of March 31, 2008, NUCRYST had $23.2 million in cash and cash equivalents, as compared to $17.8 million on December 31, 2007. Further financial information follows at the end of the release.

"We are highly focused on strengthening our core business and we continue to pursue additional opportunities for our nanocrystalline silver based products," said Thomas E. Gardner, Chairman and Chief Executive Officer of NUCRYST. "In addition, we are continuing our focus on improving operating efficiencies and have recently announced further steps to reduce costs, including consolidating management of our research and development organization."

First Quarter 2008 Financial Detail

For the quarter ended March 31, 2008, NUCRYST reported total revenues of $5.2 million, flat over the same period in 2007. Wound care product revenues in the first quarter of 2008 were $6.3 million, an increase of 21% from the same period in 2007. The increase in revenues is primarily due to increased manufacturing cost reimbursement received from Smith & Nephew driven by increased product orders received from and ship
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. NUCRYST Announces Management Realignment and R&D Portfolio Change
2. NUCRYST Announces Senior Management Change
3. NUCRYST Pharmaceuticals announces year-end results
4. NUCRYST Pharmaceuticals announces 2007 third quarter results
5. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
6. NUCRYST and Smith & Nephew Revise Agreements
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Bank of America Healthcare Conference
8. NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program
9. WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
10. Rigel Announces First Quarter 2008 Financial Results
11. BioForm Medical Announces Extension of Lock-Up Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... caring, conscientious practice you have ever been a part of. We ... we can help to achieve this goal and meet your expectations." ... ... The Dermatology Center of Dallas, a Dallas based, full-service medical and ... Foshee, MD in their practice. Dr. Foshee joins James H. ...
(Date:12/15/2009)... the release of a new report titled, “Incontinence Devices Markets ... devices used to treat and manage urinary incontinence. , ... ... -- Marketstrat is pleased to announce the release of a ... specifically addresses world markets for clinical devices used to treat ...
(Date:12/14/2009)... Young Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and ... -- Nearly all unmarried young adults ages 18-29 believe ... men and 86% of women) and say that it ... now (86% of men and 88% of women), according ... Prevent Teen and Unplanned Pregnancy. Even so: ,, ...
(Date:12/14/2009)... ABBOTT PARK, Ill. and HOLLYWOOD, Fla., Dec. ... ABT ) announced today a definitive agreement ... LIMS ), a leading provider of laboratory ... in cash. ,, The acquisition strengthens ... market, providing advanced web-based applications to help ...
(Date:12/14/2009)... -- The National Organization for Rare Disorders (NORD) today ... lifetime and annual health insurance caps. In a ... distributed widely on Capitol Hill, NORD said the current ... caps to continue for most Americans, contrary to what ... reform and welcomes the promises made by President Obama ...
Breaking Medicine News(10 mins):Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2
... why some nonsmokers contract the disease, study says , , TUESDAY, ... the risk of lung cancer, even in nonsmokers, researchers report. ... gene double someones risk of developing lung cancer, regardless of ... why some nonsmokers develop the disease, said study author Dr. ...
... SMTS ) announced today that it has received ... to expand the labeling for its,INVOS Cerebral/Somatic Oximeter System., ... support our ongoing efforts,in the pediatric and neonatal ICU ... and CEO. "First, the 510(k) expands,the indication for use ...
... Academy of General,Dentistry (AGD) applauds the recent introduction ... Sen. Benjamin Cardin (D-MD) and Sen. Susan,Collins (R-ME). ... a,multi-faceted approach to oral health care through the ... assess existing federal oral health,programs and recommend improvements., ...
... Md., and Deerfield, Ill., May 27, 2008 Sucampo ... Inc. today announced that AMITIZA (lubiprostone) 8 mcg capsules ... U.S. for the treatment of Irritable Bowel Syndrome with ... AMITIZA 24 mcg capsules have been available by prescription ...
... guest editorial published in the June issue of the ... National Institute of Dental and Craniofacial Research (NIDCR) in ... United States. Authored by NIDCR Director Lawrence A. Tabak ... oral health research and the traditional research community can ...
... The,Biomedical Excellence for Safer Transfusion (BEST) Collaborative ... and medical,implications of several recent papers purporting to ... Cells leads to greater risk. The organization,will highlight ... and Human,Services (HHS) meeting of the Advisory Committee ...
Other Medicine News:Health News:Common Genetic Variant Tied to Lung Cancer Risk 2Health News:Common Genetic Variant Tied to Lung Cancer Risk 3Health News:Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling 2Health News:AGD Applauds Sen. Cardin Oral Health Initiative Bill; Urges All Senators to Co-Sponsor Measure 2Health News:AMITIZA 8 mcg now available to treat irritable bowel syndrome 2Health News:AMITIZA 8 mcg now available to treat irritable bowel syndrome 3Health News:NIDCR strategies for future scientific success 2Health News:International Research Organization Responds to Recent Studies Purporting to Show That Transfusion of Older Red Blood Cells Leads to Greater Risk 2Health News:International Research Organization Responds to Recent Studies Purporting to Show That Transfusion of Older Red Blood Cells Leads to Greater Risk 3
(Date:12/14/2009)... Dec. 14 According to Millennium Research ... market intelligence, increased use of safety devices for ... be a key driver of the enteral feeding ... MRG,s new US and European Markets for ... the giving set segment will experience the greatest ...
(Date:12/14/2009)... 14 Mylan Inc. (Nasdaq: MYL ... added to the NASDAQ-100 Index Dec. 21. Mylan,s ... PowerShares QQQ. ,, Mylan Chairman and CEO Robert ... join NASDAQ,s most widely followed index of leading ... for Mylan and reflects the rapid growth and ...
(Date:12/14/2009)... -- Pf enex Inc. announced today ... an affiliate, an exclusive worldwide license to Pf ... technology for the production of specific proteins ... vaccine candidate. ,, Under the terms of the ... $52 million in upfront and milestone payments as well ...
Breaking Medicine Technology:Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 2Enteral Feeding Device Market To Generate More Than $700 Million in the US & Europe by 2014 3Mylan Added to NASDAQ-100 Index 2Altcharge com Announces New Services in the Processing Industry 61099 1Altcharge com Announces New Services in the Processing Industry 61099 2Particle Sciences Acquires Additional Space for Operations 14790 1Particle Sciences Acquires Additional Space for Operations 14790 2Amedica Announces New Product Offering 14788 1Amedica Announces New Product Offering 14788 2
... Anpath Group, Inc.,(OTC Bulletin Board: ANPG), reported today ... that its EnviroTru(R),disinfectant has been assigned a commodity ... the State of Florida. The Company reported,that its ... http://www.aworldofgreen.com ),worked with the DMS to have ...
... An overwhelming number of,Americans with memory concerns ... despite visits within the past six months, according ... in the Alzheimer,s Foundation of,America (AFA) National Memory ... results at a poster session at the Alzheimer,s,Association,s ...
Other Medicine Technology:Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 2Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida 3Alzheimer's Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors 2Alzheimer's Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors 3
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... and specific second-generation peptide-based test, DIASTAT Anti-CCP* ... of autoantibodies against the cyclic citrullinated peptide ... serum or plasma. Enabling early and accurate ... an additional tool in the diagnosis and ...
... Rapid Plasma Reagin ... rapid detection and quantitative ... serum or plasma. Uses ... to detect reagin. Kits ...
Hemagglutination slide test for the qualitative detection and quantitative determination of antibodies to streptococcal extracellular antigens in serum, plasma, or whole blood....
Medicine Products: